Atara Biotherapeutics, Inc.ATRANASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank85
5Y CAGR+2.4%
Year-over-Year Change
Year-over-year free cash flow growth rate
5Y CAGR
+2.4%/yr
Long-term compound
Percentile
P85
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 26.13% |
| 2024 | 64.49% |
| 2023 | 29.28% |
| 2022 | -18.83% |
| 2021 | -24.74% |
| 2020 | 23.24% |
| 2019 | -11.90% |
| 2018 | -100.21% |
| 2017 | -70.88% |
| 2016 | -68.36% |